Novartis’ and Alcon’s $345 Million FCPA Case Signals Increased Scrutiny of Gifts and Entertainment and Renewed Focus on Scientific Studies
On June 25, 2020, Novartis AG, a Swiss multinational pharmaceutical company, and two subsidiaries reached a combined $345 million resolution with the U.S.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.